Skip to main content

Central Nervous System Brachytherapy

  • Chapter
  • First Online:
Handbook of Image-Guided Brachytherapy

Abstract

Resected brain metastases have a high rate of local recurrence without adjuvant therapy. Adjuvant whole-brain radiotherapy (WBRT) remains the standard of care with a local control rate >90 %. However, WBRT is delivered over 10–15 days, which can delay other therapy and is associated with acute and long-term toxicities. Permanent brachytherapy implants can be used at the time of surgical resection, which both provides necessary adjuvant therapy as well as allowing the patient’s disease to be treated fully in one visit. Several radioisotopes have been used in central nervous system brachytherapy, including low dose rate Iodine-125 and Cesium-131. Cesium-131 in particular provides an excellent balance between optimizing local control and minimizing toxicities associated with radiation treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Petr MJ, McPherson CM, Breneman JC, et al. Management of newly diagnosed single brain metastasis with surgical resection and permanent I-125 seeds without upfront whole brain radiotherapy. J Neurooncol. 2009;92:393–400.

    Article  PubMed  Google Scholar 

  2. Ruge MI, Suchorska B, Maarouf M, et al. Stereotactic 125iodine brachytherapy for the treatment of singular brain metastases: closing a gap? Neurosurgery. 2011;68:1209–18. Discussion 1218–1209.

    Article  PubMed  Google Scholar 

  3. Ruge MI, Kickingereder P, Grau S, et al. Stereotactic biopsy combined with stereotactic (125)iodine brachytherapy for diagnosis and treatment of locally recurrent single brain metastases. J Neurooncol. 2011;105:109–18.

    Article  PubMed  Google Scholar 

  4. Wernicke AG, et al. Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases. J Neurosurg. 2014;121:338–48.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Wernicke AG, Smith AW, Taube S, Yondorf M, Trichter S, Nedialkova L, Sabbas A, Christos P, Ramakrishna R, Pannullo S, Stieg P, Schwartz T. Cesium-131 brachytherapy for recurrent brain metastases offers durable salvage treatment for previously irradiated patients. J Neurosurg. 2016;1–8 [Epub ahead of print].

    Google Scholar 

  6. Soffietti R, Kocher M, Abacioglu UM, et al. A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol. 2013;31:65–72.

    Article  PubMed  Google Scholar 

  7. Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009;10:1037–44.

    Article  PubMed  Google Scholar 

  8. Molenaar R, Wiggenraad R, Verbeek-de Kanter A, et al. Relationship between volume, dose and local control in stereotactic radiosurgery of brain metastasis. Br J Neurosurg. 2009;23:170–8.

    Article  PubMed  Google Scholar 

  9. Sneed PK, Mendez J, Vemer-van den Hoek JG, et al. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. J Neurosurg. 2015;123:373–86.

    Article  CAS  PubMed  Google Scholar 

  10. Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys. 2000;47:291–8.

    Article  CAS  PubMed  Google Scholar 

  11. Yang R, Wang J, Zhang H. Dosimetric study of Cs-131, I-125, and Pd-103 seeds for permanent prostate brachytherapy. Cancer Biother Radiopharm. 2009;24:701–5.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Gabriella Wernicke MD, MS .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Wernicke, A.G., Taube, S., Smith, A.W., Parashar, B. (2017). Central Nervous System Brachytherapy. In: Mayadev, J., Benedict, S., Kamrava, M. (eds) Handbook of Image-Guided Brachytherapy. Springer, Cham. https://doi.org/10.1007/978-3-319-44827-5_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-44827-5_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-44825-1

  • Online ISBN: 978-3-319-44827-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics